S. K. FINEBERG, M.D., F.A.C.P.
The recent popular acceptance of oral hypoglycemic agents necessitates renewed and heavy emphasis on the primary importance of controlling obesity in the management of concomitant diabetes mellitus. The use of these agents in the treatment of maturity-onset, mild diabetes, at least, is now firmly entrenched and widespread. Although they have proved their worth, in selected cases, by providing control of the disease while freeing significant numbers of this type of diabetic patient from the pain and inconvenience of daily insulin injections, there is still foremost among the dangers inherent in this long sought-for modality an enormous potentiality for abuse.
FINEBERG SK. OBESITY AND DIABETES: A REËVALUATION1. Ann Intern Med. ;52:750–760. doi: 10.7326/0003-4819-52-4-750
Download citation file:
Published: Ann Intern Med. 1960;52(4):750-760.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Obesity.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use